Truveta Research found that for every 1,000 patients with a first-time GLP-1 prescription, 42 were diagnosed with type 2 diabetes within 15 days in 2024, up from 32 in 2020
The company's quick withdrawal of its compounded GLP-1 pill, just days after its launch, signals a recognition of the escalating legal and regulatory pressure
-Syn interacts with Fe + and Fe + , promoting lipid peroxidation and ROS generation, which accelerate oxidative stress and ultimately drive ferroptotic neuronal loss (248)
Strengths and limitations The strength of this review is a focus on the period of LC treatment, very important aspect often missed in many articles dealing with this supplement
Beginning in Fall 2022, the news media has reported extensively on the use of Glucagon-like peptide-1 receptor agonist (GLP-1s) for weight loss (Belluz, 2023)